You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Caveolin 1 antibody (ab39541)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-Caveolin 1 antibody
See all Caveolin 1 products (19) ...

Description

Rabbit polyclonal to Caveolin 1

Specificity

This antibody detects endogenous levels of total Caveolin 1 protein.

Tested applications

WB, ELISA, IHC-Pmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Immunogen

The antiserum was produced against synthesized non phosphopeptide derived from human Caveolin 1 around the phosphorylation site of Tyrosine 14.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: 50% Glycerol, PBS(without Mg2+ and Ca2+), 150mM Sodium chloride, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Purification notes

This antibody was affinity purified from rabbit antiserum by affinity chromatography using epitope specific immunogen.

Clonality

Polyclonal

Isotype

IgG

  • Western blot - Caveolin 1 antibody (ab39541)Western blot - Caveolin 1 antibody (ab39541) image (enlarge)

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-Caveolin 1 antibody(ab39541)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-Caveolin 1 antibody(ab39541) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab39541 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity (By similarity). Involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Its binding to DPP4 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. Recruits CTNNB1 to caveolar membranes and may regulate CTNNB1-mediated signaling through the Wnt pathway.

Tissue specificity

Expressed in muscle and lung, less so in liver, brain and kidney.

Involvement in disease

Defects in CAV1 are the cause of congenital generalized lipodystrophy type 3 (CGL3) [MIM:612526]; also called Berardinelli-Seip congenital lipodystrophy type 3 (BSCL3). Congenital generalized lipodystrophies are autosomal recessive disorders characterized by a near absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes.

Sequence similarities

Belongs to the caveolin family.

Post-translational
modifications

The initiator methionine for isoform Beta is removed during or just after translation. The new N-terminal amino acid is then N-acetylated.

Cellular localization

Golgi apparatus membrane. Cell membrane. Membrane > caveola. Membrane raft. Colocalized with DPP4 in membrane rafts. Potential hairpin-like structure in the membrane. Membrane protein of caveolae.

Target information above from: UniProt accessionQ03135 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • VIP 21 antibody
  • CAV 1 antibody
  • CAV antibody
  • CAV1 antibody
  • CAV1_HUMAN antibody
  • caveolae protein, 22 kD antibody
  • caveolin 1 alpha isoform antibody
  • caveolin 1 beta isoform antibody
  • Caveolin 1 caveolae protein 22kDa antibody
  • Caveolin-1 antibody
  • Caveolin1 antibody
  • cell growth-inhibiting protein 32 antibody
  • MSTP085 antibody
  • OTTHUMP00000025031 antibody
  • VIP 21 antibody
  • VIP21 antibody
see all

Anti-Caveolin 1 antibody images:

  Western blot - Caveolin 1 antibody (ab39541)

Western blot - Caveolin 1 antibody (ab39541)



Predicted band size : 20 kDa


Western blot analysis of the extracts from NIH/3T3 cells untreated or treated with H2O2 using Caveolin 1 antibod (ab39541) and Caveolin 1(Phospho-Tyr14) antibody.

Lane 1: Using ab39541;

Lane 2: Using ab39541 preincubated with synthesized peptide;

Lane 3: Using Caveolin 1(Phospho-Tyr14) antibody;

Lane 4: Using Caveolin 1(Phospho-Tyr14) antibody preincubated with synthesized peptide.

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-Caveolin 1 antibody(ab39541)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-Caveolin 1 antibody(ab39541)

ab39541 staining caveolin in human lung.
Left panel: with primary antibody at 1 ug/ml. Right panel: isotype control.
Sections were stained using an automated system (DAKO Autostainer Plus), at room temperature: sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers EDTA pH 9.0. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

References for Anti-Caveolin 1 antibody (ab39541)

ab39541 has not yet been referenced specifically in any publications.

Publishing research using ab39541? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"